InfuCare Rx Founder-Led Buyback of One Equity Partners Stake
July 11, 2025
One Equity Partners has exited its investment in InfuCare Rx via a strategic, founder-led equity buyback. InfuCare Rx is a nationwide specialty infusion therapy provider treating complex and chronic conditions, operating three segments (IG Therapy, Specialty Infusion, Bleeding Disorders) and serving thousands of patients across all 50 states.
- Buyers
- Deven Patel / InfuCare Rx management (founder-led equity buyback)
- Targets
- InfuCare Rx
- Sellers
- One Equity Partners
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
One Equity Partners Completes Strategic Investment in InfuCare Rx
January 12, 2022
Healthcare Services
One Equity Partners (OEP) has completed a strategic investment in InfuCare Rx, a Fairfield, New Jersey–headquartered provider of specialty home infusion therapies and clinical therapy management. Financial terms were not disclosed; OEP said the capital will be used to accelerate growth, expand into new regions and scale InfuCare Rx's digital care management platform serving patients with complex chronic conditions.
-
BioMatrix Specialty Pharmacy Acquires InfuCare LTD (Tyler, TX)
July 6, 2021
Healthcare Services
BioMatrix Specialty Pharmacy, based in Plantation, Florida, has acquired InfuCare LTD, a home infusion specialty pharmacy in Tyler, Texas. The transaction adds a Texas brick-and-mortar location to BioMatrix's national footprint and expands its infusion capabilities, payer contracts, and access to covered lives for therapies such as IVIG, anti-infectives, and parenteral nutrition.
-
Shore Capital Partners Recapitalizes Reliant Healthcare and Merges It with Care Fusion Rx
November 23, 2025
Healthcare Services
Shore Capital Partners, via its Healthcare Advantage Fund, completed a majority recapitalization of Reliant Healthcare and merged Reliant with California-based Care Fusion Rx to form a national infusion therapy platform. The combined company will expand home and ambulatory infusion services, leveraging complementary geographic footprints and clinical capabilities to drive growth through new center openings, home infusion expansion, and further acquisitions.
-
Frontline Healthcare Partners Recapitalizes LivWell Infusions
August 16, 2022
Healthcare Services
Frontline Healthcare Partners completed a recapitalization and growth investment in LivWell Infusions, an outpatient infusion and injection therapy provider founded in Scottsdale, Arizona. LivWell operates ambulatory infusion centers and practice management services across multiple states (Arizona, California, New Mexico, Indiana and Pennsylvania) and will use the capital and Frontline's expertise to accelerate geographic expansion and scale its site-of-care model.
-
Rubicon Founders Acquires Majority Stake in Horizon Infusions
February 7, 2025
Healthcare Services
Rubicon Founders has made a majority investment in Horizon Infusions, Ohio’s largest network of ambulatory infusion centers, with BroadOak Capital remaining as a minority investor. The investment will support Horizon’s growth from its 21 centers in Ohio and enable expansion into new markets while preserving the company’s patient-centered, outpatient infusion model.
-
Great Hill Partners Invests $100M in IVX Health
September 21, 2021
Healthcare Services
Great Hill Partners completed a $100 million Series F minority growth investment in IVX Health to fund the outpatient infusion provider's expansion into new markets. The capital will be used to accelerate market entry and broaden IVX Health's network of infusion and injection centers across the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.